| Autor: |
Adams R; Richard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Wilson R; Richard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Brown L; Richard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Maughan T; Richard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom. |
| Abstrakt: |
Competing Interests: Richard AdamsHonoraria: Merck Serono, Servier, AmgenConsulting or Advisory Role: Merck Serono, Amgen, Servier, BayerSpeakers' Bureau: Merck SeronoResearch Funding: AstraZeneca (Inst), Merck Sharp & Dohme (Inst)Travel, Accommodations, Expenses: Servier, Amgen, Merck Serono, AstraZeneca Richard WilsonHonoraria: Servier, Amgen, Bristol Myers SquibbConsulting or Advisory Role: Amgen, CV6 Therapeutics, Pierre Fabre, Amphista Therapeutics (Inst), NuCana (Inst)Travel, Accommodations, Expenses: Amgen, Pierre Fabre Louise BrownResearch Funding: AstraZeneca (Inst) Tim MaughanEmployment: AstraZenecaConsulting or Advisory Role: Vertex, Pierre FabreResearch Funding: AstraZeneca (Inst), PsiOxus Therapeutics (Inst), Merck KGaA (Inst), Almac Diagnostics (Inst)Patents, Royalties, Other Intellectual Property: patent pendingNo other potential conflicts of interest were reported. |
